Dallas, TX: ReportsandReports announce it will carry China In Vitro Diagnostics Market Outlook to 2016 Market Research Report in its Store.
Browse complete Report on: http://www.reportsandreports.com/market-reports/china-in-vitro-diagnostics-market-outlook-to-2016/
GlobalData’s new report, “China In Vitro Diagnostics Market Outlook to 2016” provides key market data on the China In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
* Market size and company share data for In Vitro Diagnostics (IVD) market categories clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
* Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
* 2009 company shares and distribution shares data for each of the seven market categories.
* Global corporate-level profiles of key companies operating within the China In Vitro Diagnostics (IVD) market.
* Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
* Develop business strategies by identifying the key market categories and segments poised for strong growth.
* Develop market-entry and market expansion strategies.
* Design competition strategies by identifying who-stands-where in the China In Vitro Diagnostics (IVD) competitive landscape.
* Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
* What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 What is This Report About? 16
3 In Vitro Diagnostics In China 17
3.1 In Vitro Diagnostics, Market Segmentation 17
3.2 In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016 18
3.3 In Vitro Diagnostics Market, China, Revenue Mix ($m), 2009 20
3.4 In Vitro Diagnostics Market, China, Category Contribution (%), 2009 21
3.5 In Vitro Diagnostics, China, Company Share (2008-2009) 27
4 Clinical Chemistry In China 28
4.1 Clinical Chemistry, Market Segmentation 28
4.2 Clinical Chemistry Market, China, Revenue Mix ($m), 2009 29
4.3 Clinical Chemistry Market, China, Category Contribution (%), 2009 30
4.4 Clinical Chemistry Overall Revenue (2002-2016) 31
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 35
4.4.2 Urine Analysis Revenue (2002-2016) 39
4.5 Clinical Chemistry Distribution Share (2008-2009) 43
4.6 Clinical Chemistry, China, Company Share (2008-2009) 44
5 Genetic Testing In China 46
5.1 Genetic Testing, Market Segmentation 46
5.2 Genetic Testing Market, China, Revenue Mix ($m), 2009 47
5.3 Genetic Testing Market, China, Category Contribution (%), 2009 48
5.4 Genetic Testing Overall Revenue (2002-2016) 49
5.5 Genetic Testing Distribution Share (2008-2009) 53
5.6 Genetic Testing, China, Company Share (2008-2009) 54
6 Haematology In China 55
6.1 Haematology, Market Segmentation 55
6.2 Haematology Market, China, Revenue Mix ($m), 2009 56
6.3 Haematology Market, China, Category Contribution (%), 2009 57
6.4 Haematology Overall Revenue (2002-2016) 58
6.4.1 Haematology Reagents Revenue (2002-2016) 62
6.4.2 Immunohaematology Revenue (2002-2016) 66
6.4.3 Haemostasis Revenue (2002-2016) 70
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 74
6.4.5 Haematology Cell Counters Revenue (2002-2016) 78
6.5 Haematology Distribution Share (2008-2009) 82
6.6 Haematology, China, Company Share (2008-2009) 83
7 Histology And Cytology In China 85
7.1 Histology and Cytology, Market Segmentation 85
7.2 Histology and Cytology Market, China, Revenue Mix ($m), 2009 86
7.3 Histology And Cytology Market, China, Category Contribution (%), 2009 87
7.4 Histology And Cytology Overall Revenue (2002-2016) 88
7.4.1 Histology Revenue (2002-2016) 92
7.5 Histology And Cytology Distribution Share (2008-2009) 96
7.6 Histology And Cytology, China, Company Share (2008-2009) 97
8 Immuno Chemistry In China 98
8.1 Immuno Chemistry, Market Segmentation 98
8.2 Immuno Chemistry Market, China, Revenue Mix ($m), 2009 99
8.3 Immuno Chemistry Market, China, Category Contribution (%), 2009 100
8.4 Immuno Chemistry Overall Revenue (2002-2016) 101
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 105
8.4.2 Drug Related Testing Revenue (2002-2016) 109
8.4.3 Endocrinology Tests Revenue (2002-2016) 112
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 116
8.5 Immuno Chemistry Distribution Share (2008-2009) 120
8.6 Immuno Chemistry, China, Company Share (2008-2009) 121
9 Infectious Immunology In China 123
9.1 Infectious Immunology, Market Segmentation 123
9.2 Infectious Immunology Market, China, Revenue Mix ($m), 2009 124
9.3 Infectious Immunology Market, China, Category Contribution (%), 2009 125
9.4 Infectious Immunology Overall Revenue (2002-2016) 126
9.5 Infectious Immunology Distribution Share (2008-2009) 130
9.6 Infectious Immunology, China, Company Share (2008-2009) 131
10 Microbiology Culture In China 133
10.1 Microbiology Culture, Market Segmentation 133
10.2 Microbiology Culture Market, China, Revenue Mix ($m), 2009 134
10.3 Microbiology Culture Market, China, Category Contribution (%), 2009 135
10.4 Microbiology Culture Overall Revenue (2002-2016) 136
10.4.1 Microbiology Analyzers Revenue (2002-2016) 140
10.5 Microbiology Culture Distribution Share (2008-2009) 143
10.6 Microbiology Culture, China, Company Share (2008-2009) 144
11 Overview of Key Companies in China In Vitro Diagnostics Market 145
11.1 F. Hoffmann-La Roche Ltd. 145
11.1.1 Company Overview 145
11.1.2 Share in the China In Vitro Diagnostics Market 145
11.2 Siemens Healthcare 146
11.2.1 Company Overview 146
11.2.2 Share in the China In Vitro Diagnostics Market 146
11.3 Abbott LaboratoriesCompany Overview 147
11.3.1 Share in the China In Vitro Diagnostics Market 147
11.4 Beckman Coulter, Inc. 148
11.4.1 Company Overview 148
11.4.2 Share in the China In Vitro Diagnostics Market 148
11.5 Sysmex Corporation 149
11.5.1 Company Overview 149
11.5.2 Share in the China In Vitro Diagnostics Market 149
11.6 Mindray Medical International Limited 150
11.6.1 Company Overview 150
11.6.2 Share in the China In Vitro Diagnostics Market 150
11.7 OLYMPUS CORPORATION 151
11.7.1 Company Overview 151
11.8 Inverness Medical Innovations, Inc. 151
11.8.1 Company Overview 151
11.9 Becton, Dickinson and Company 152
11.9.1 Company Overview 152
11.10 bioMerieux S.A. 152
11.10.1 Company Overview 152
11.11 Bio-Rad Laboratories, Inc. 153
11.11.1 Company Overview 153
11.12 Hologic, Inc. 153
11.12.1 Company Overview 153
11.13 Ventana Medical Systems, Inc. 154
11.13.1 Company Overview 154
11.14 Ortho-Clinical Diagnostics Inc. 154
11.14.1 Company Overview 154
11.15 DiaSorin S.p.A 154
11.15.1 Company Overview 154
11.16 Qiagen N.V. 155
11.16.1 Company Overview 155
11.17 Gen-Probe Incorporated 155
11.17.1 Company Overview 155
11.18 Phadia AB 155
11.18.1 Company Overview 155
11.19 Chengdu Perlong Medical Equipment Co., Ltd. 156
11.19.1 Company Overview 156
11.20 Shanghai Kehua Bio-engineering Co., Ltd. 156
11.20.1 Company Overview 156
11.21 China Medical Technologies, Inc. 156
11.21.1 Company Overview 156
11.22 Shanghai Genomics, Inc. 157
11.22.1 Company Overview 157
11.23 Beijing Chemclin Biotech Co., Ltd. 157
11.23.1 Company Overview 157
11.24 Beijing Pason Pharmaceuticals Inc. 157
11.24.1 Company Overview 157
11.25 Jingmei Biotech Co.,Ltd. 158
11.25.1 Company Overview 158
11.26 Beijing Bio-Ekon Biotechnology Co., Ltd. 158
11.26.1 Company Overview 158
11.27 China Sky One Medical, Inc. 158
11.27.1 Company Overview 158
11.28 Beijing Sekisui Trank Medical Technology Co., Ltd. 159
11.28.1 Company Overview 159
11.29 Shanghai Xunda Medical Instrument Co.,Ltd 159
11.29.1 Company Overview 159
11.30 Shanghai Fosun Medical Technology Development Co., Ltd. 159
11.30.1 Company Overview 159
11.31 Sichuan Nigale Biomedical Inc. 160
11.31.1 Company Overview 160
11.32 URIT Medical Electronic Group Co., Ltd 160
11.32.1 Company Overview 160
11.33 Rayto Life and Analytical Sciences Co., Ltd. 160
11.33.1 Company Overview 160
11.34 Bioson Corporation 161
11.34.1 Company Overview 161
11.35 Da An Gene Co., Ltd. 161
11.35.1 Company Overview 161
11.36 Shenzhen PG Biotech Co., Ltd. 161
11.36.1 Company Overview 161
11.37 Harbin First Bio-Engineering Co., Ltd 161
11.37.1 Company Overview 161
11.38 Beijing Shining Sun Technology Co., Ltd. 162
11.38.1 Company Overview 162
11.39 InTec Products, Inc 162
11.39.1 Company Overview 162
11.40 Zhongshan Bio-Tech Co., Ltd 162
11.40.1 Company Overview 162
11.41 Beijing BGI-GBI Biotech Co.,Ltd. 162
11.41.1 Company Overview 162
11.42 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., 163
11.42.1 Company Overview 163
11.43 GUANG ZHOU BGH BIOCHEMICAL CO.,LTD 163
11.43.1 Company Overview 163
12 In Vitro Diagnostics Market Pipeline Products 164
12.1 Clinical Chemisty Market Pipeline Products 164
12.2 Immuno Chemistry Market Pipeline Products 166
12.3 Haematology Market Pipeline Products 167
12.4 Infectious Immunology Market Pipeline Products 168
12.5 Microbiology Culture Market Pipeline Products 170
12.6 Histology and Cytology Market Pipeline Products 171
12.7 Genetic Testing Market Pipeline Products 172
13 Financial Deals Landscape 174
13.1 Acquisition 174
13.1.1 CCS Capital to Acquire Beijing Biochem Hengye Science & Technology Development 174
13.1.2 bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai) 175
13.1.3 PerkinElmer Completes Acquisition Of Sym-Bio LifeScience 176
13.2 Partnerships 177
13.2.1 QIAGEN Enters Into Distribution Agreement With Celera 177
13.2.2 Sequenom Enters Into Licensing Agreement With Optherion 178
13.2.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 179
13.2.4 Response Biomedical Enters Into An Agreement With Guangzhou Wondfo Biotech 180
13.2.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 181
13.2.6 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 182
13.2.7 DxS Signs Cross-Licensing Agreement With Epigenomics 183
14 Recent Developments 184
14.1 Strategy and Business Planning 184
14.1.1 Sep 08, 2009: Qiagen Inaugurates New Asia Headquarters In Shanghai 184
14.2 Legal and Regulatory 184
14.2.1 Mar 08, 2010: Chinmax Medical Systems Files Complaint In China Against Inverness Medical Beijing Over Distribution Rights 184
14.3 Product News 185
14.3.1 Jun 09, 2010: China Medical Technologies Receives SFDA Approval For Its SPR-Based HPV-DNA Chip 185
14.3.2 Apr 14, 2010: HairDX Forms Alliance With GBIL To Distribute HairDX Genetic Hair Loss Tests In Hong Kong And Singapore 185
14.3.3 Dec 01, 2009: China Sky One Medical Distributes AMI Diagnostic Kit And Human Urinary Albumin Elisa Kit In Southeast Asia Through MDK 186
14.3.4 Nov 25, 2009: China Sky One Medical Achieves Milestone For Its Two New Biological Testing Kits 186
14.3.5 Oct 19, 2009: China Medical Technologies Receives SFDA Clearance For SPR System 187
15 Appendix 188
15.1 Definitions of Markets Covered in the Report 189
15.1.1 In Vitro Diagnostics 189
15.2 Research Methodology 197
15.3 Secondary Research 198
15.4 Primary Research 198
15.5 Models 199
15.6 Forecasts 199
15.7 Expert Panels 199
15.8 GlobalData Consulting 199
15.9 Currency Conversion 200
15.10 Contact Us 200
15.11 Disclaimer 200
Browse complete Report on: http://www.reportsandreports.com/market-reports/china-in-vitro-diagnostics-market-outlook-to-2016/
Browse all Medical Devices Market Research Reports on:
http://www.reportsandreports.com/market-research/medical-devices/
Browse all GlobalData Market Research Reports on: publisher
http://www.reportsandreports.com/Publishers/globaldata/
Browse all Latest Report on: fixed
http://www.reportsandreports.com/LatestReport.aspx
Related Reports:
Japan In Vitro Diagnostics Market Outlook to 2016
http://www.reportsandreports.com/market-reports/japan-in-vitro-diagnostics-market-outlook-to-2016/
India In Vitro Diagnostics Market Outlook to 2016
http://www.reportsandreports.com/market-reports/india-in-vitro-diagnostics-market-outlook-to-2016/
About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/